Şule Arıcı

Dr. Şule Arıcı

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BÇBerna Şaylan Çevi̇k
Berna Şaylan Çevi̇k
ŞAŞule Arıcı
Şule Arıcı
ZEZeynep Ergenç
Zeynep Ergenç
EKEda Kepenekli̇
Eda Kepenekli̇
ÖGÖzge Günal
Özge Günal
NYNurhayat Yakut
Nurhayat Yakut
Approximately 40 million individuals worldwide have been infected with SARS-CoV-2, the virus responsible for the novel coronavirus disease-2019 (COVID-19). Despite the current literature about the cardiac effects of COVID-19 in children, more information is required. We aimed to determine both cardiovascular and arrhythmia assessments via electrocardiographic and echocardiographic parameters. We evaluated 70 children who were hospitalized with COVID-19 infections and 70 children as the normal control group through laboratory findings, electrocardiography (ECG), and transthoracic echocardiography (TTE). We observed significantly increased levels of Tp-Te, Tp-Te/QT, and Tp-Te/QTc compared with the control group. Twenty-five of 70 (35.7%) patients had fragmented QRS(fQRS) without increased troponin levels. None of the patients had pathologic corrected QT(QTc) prolongation during the illness or its treatment. On TTE, 20 patients had mild mitral insufficiency, among whom only five had systolic dysfunction (ejection fraction <55%). There was no significant difference between the patient and control groups, except for isovolumic relaxation time (IVRT) in terms of mean systolic and diastolic function parameters. The IVRT of COVID patients was significantly lower than that of control group. Despite all the adult studies, the effects of COVID?19 on myocardial function are not well established in children. The thought that children are less affected by the illness may be a misconception.

30 October 2024 in Marmara Medical Journal
Verified
Journal Article
Open access
PDF file
ÖSÖzlem Sarısoy
Özlem Sarısoy
ŞAŞule Arıcı
Şule Arıcı
EBEce Demirci Bodur
Ece Demirci Bodur
OTOguzhan Tezel
Oguzhan Tezel
HAHarika Alpay
Harika Alpay
FAFigen Akalın
Figen Akalın
Objective: We aimed to evaluate cardiovascular risks and influencing factors by measuring aortic elasticity parameters and carotid intima thickness in children with cronic kidney disease (CKD), and also evaluated the hydration status of patients with bioimpedance spectroscopy (BIS) measurements and investigated the effect of hydration status on vascular functions. Patients and Methods: The study group included an average of 13.3 ± 3.7 years (16 girls and 22 boys, 38 CKD patients), control group on average 12.1 ± 2.9 (16 girls and 15 boys, 31 healthy children). Systolic and diastolic diameters of the aortic annulus and aorta at each level were obtained; z-scores, aortic strain, distensibility, stiffness index were calculated. Carotid intima-media thickness and flow – mediated dilatation were studied. Bioimpedance spectroscopy was performed to all patients. Results: Interventricular septum and left atrial (p=0.002, p=0.013), sinus valsalva and sinotubular junction z scores (p=0.009, p=0.012) were found to be higher and distensibility and strain decreased, stiffness index increased in the abdominal aorta of patients with CKD (p=0.007, p=0.002, p=0.004). Patients with CKD had statistically significant over-hydration. Conclusion: Vascular wall changes that affect the elastic properties of the aortic wall begin to develop in childhood in patients with CKD.

4 March 2024 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
ŞAŞule Arıcı
Şule Arıcı
FAFigen Akalın
Figen Akalın
BGBilgen Bilge Geckinli
Bilgen Bilge Geckinli
Objectives: Carvajal syndrome is a very rare autosomal recessive cardiocutaneous disorder caused by a desmosomal mutation in exon 24 of the desmoplakin gene. It manifests with woolly hair, epidermolytic palmoplantar keratoderma, and arrhythmogenic right ventricular cardiomyopathy. We herein present a patient with heart failure and dilated cardiomyopathy who was diagnosed with Carvajal syndrome because of dermatologic manifestations.Case Presentation: A seven-year-old girl was referred to our clinic due to decompensated heart failure and clinical deterioration. The patient had severe weakness, tachycardia, and tachypnea. She had a complaint of getting tired quickly for three weeks, and she had shortness of breath and abdominal pain for the last two days. She had hepatomegaly and woolly hair. Mild keratoderma was present on the soles of her feet. Echocardiography demonstrated biventricular dilatation, significantly impaired left ventricular systolic function (ejection fraction 22%), and moderate to severe mitral and tricuspid regurgitation. Molecular genetic evaluation was performed because of cutaneous and cardiac findings, which demonstrated a desmoplakin gene mutation. Homozygous mutation c.4297C > T (p.Gln1433*) was identified in desmoplakin gene, and the diagnosis of Carvajal syndrome was confirmed.Conclusions: Syndromic types of arrhythmogenic right ventricular cardiomyopathy such as Carvajal syndrome are rare diseases. Awareness about cutaneous manifestations and genetic evaluation would help diagnosis and prevention of sudden death. Genetic counselling is needed in familial cases.

1 September 2022 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
TRTürkay Rzayev
Türkay Rzayev
ŞAŞule Arıcı
Şule Arıcı
AMASLI MEMISOGLU
ASLI MEMISOGLU
HOHulya Ozdemir
Hulya Ozdemir
HBHülya Bilgen
Hülya Bilgen
EÖEren Özek
Eren Özek
Cite this article as: Rzayev T, Arıcı S, Memişoğlu A, Özdemir H, Bilgen H, Özek E. Neonatal methemoglobinemia after subcutaneous injection of lidocaine to the mother at birth. Turk Arch Pediatr. 2022;57(5):571-572.

15 October 2025 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
ŞAŞule Arıcı
Şule Arıcı
FAFi̇gEn Akalin
Fi̇gEn Akalin
Dilated cardiomyopathy (DCM) is a major cause of heart failure and transplantation in children. Despite advances in care, predicting outcomes remains difficult. Inflammatory markers, such as the neutrophil‑to‑lymphocyte ratio (NLR) and the systemic inflammatory index (SII), have demonstrated prognostic value in adults, but their role in pediatric DCM remains unclear. The present study aimed to assess the association of NLR, SII and other clinical, laboratory and echocardiographic parameters with mortality in pediatric DCM. In the present retrospective single‑center study, 52 pediatric patients with DCM diagnosed between January 2000 and June 2021 were analyzed. Demographic, clinical, laboratory and echocardiographic data at diagnosis were collected from hospital electronic medical records. NLR and SII were calculated from complete blood counts, whereas mortality was the primary outcome. Statistical methods included receiver operating characteristic (ROC) curve analysis, Kaplan‑Meier survival estimates and Cox regression. In the present study, 16 patients (30.8%) succumbed during follow‑up, and NLR and SII were found to be significantly higher in deceased patients compared with survivors (P=0.003 and P=0.016, respectively). ROC analysis confirmed the predictive value of NLR (AUC, 0.785) and SII (AUC, 0.728). The optimal cut‑off values were >2.75 for NLR and >1,428,898 for SII. Cox regression identified parameters associated with mortality, including low serum sodium and magnesium levels, elevated NLR and SII, reduced mitral E wave velocity and positive family history of DCM. In conclusion, elevated NLR and SII at diagnosis are associated with increased mortality in pediatric patients with DCM. As cost‑effective and easily accessible markers of systemic inflammation, these indices may serve as useful adjuncts to conventional risk assessment, particularly in settings with limited access to advanced laboratory testing. However, further prospective multicenter studies are needed to validate their prognostic role.

9 April 2026 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
ŞAŞule Arıcı
Şule Arıcı
AYAyse Inci Yildirim
Ayse Inci Yildirim
GKGulperi Yagar Keskin
Gulperi Yagar Keskin
FGFatih Alparslan Genc
Fatih Alparslan Genc
ETErkan Tas
Erkan Tas
MOMehmet Ozkan
Mehmet Ozkan
Pregnant women with mechanical heart valves (MHVs) require continuous anticoagulation; however, first-trimester exposure to warfarin raises concerns regarding fetal safety. Data on long-term pediatric outcomes after low-dose warfarin exposure remain limited. This study aimed to evaluate long-term growth, neurodevelopmental, cardiac, and endocrine outcomes in children antenatally exposed to low-dose warfarin combined with enoxaparin, compared with enoxaparin alone. This single-center observational cohort study reports long-term pediatric follow-up outcomes of 32 children born to 30 women with MHVs who were enrolled at one participating center of the multicenter KYBELE study. Maternal data regarding anticoagulant therapy during pregnancy were obtained retrospectively from medical records, while pediatric data were collected through prospective clinical evaluations. Children underwent standardized assessments including physical examination, growth evaluation, Denver II developmental screening, skeletal radiography review, hearing and vision testing, electrocardiography, echocardiography, and thyroid and abdominal ultrasonography. Based on first-trimester anticoagulation regimen, children were classified as enoxaparin only (n = 12), enoxaparin plus warfarin 2.5 mg/day (n = 8), or enoxaparin plus warfarin 4 mg/day (n = 12). The median age at last follow-up was 61.5 months (range 9-168). No child had growth parameters below the 3rd percentile. The overall rate of prematurity was 19%. Although higher in children receiving enoxaparin plus warfarin (2.5 mg or 4 mg/day) compared with those receiving enoxaparin alone, the difference was not statistically significant (p = 0.6). Developmental delay on Denver II screening was identified in 2 of 32 children (p = 0.7), with no significant differences among groups. All children had normal hearing, vision, and thyroid function tests. Minor neonatal echocardiographic findings (e.g., patent ductus arteriosus or patent foramen ovale) were observed in 10 children (31%) and largely resolved during follow-up, with no child requiring cardiac intervention. No skeletal dysplasia or features suggestive of warfarin embryopathy were identified. In this single-center follow-up cohort of live-born children, first-trimester exposure to low-dose warfarin combined with enoxaparin was not associated with signals of major long-term adverse outcomes in growth, neurodevelopment, cardiac status, or thyroid function compared with enoxaparin alone. These findings support cautious use of low-dose warfarin when maternal indications exist, while underscoring the need for larger multicenter studies.